A. T. Nagao
ORCID: 0000-0002-3637-9660
· 1 paper in corpus
article
2023
Background: Long-term prophylaxis is recommended for patients with von Willebrand disease (VWD) who have a history of severe, frequent bleeds.In previous clinical trials, prophylaxis with a human plasma-derived von Willebrand factor/factor …